Reshma P. Shetty - Dec 6, 2021 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
President, COO & Founder, Director, 10%+ Owner
Signature
/s/ Karen Tepichin, Attorney-in-fact
Stock symbol
DNA
Transactions as of
Dec 6, 2021
Transactions value $
$0
Form type
4
Date filed
12/8/2021, 07:06 PM
Previous filing
Oct 4, 2022
Next filing
Oct 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Conversion of derivative security +200K 200K Dec 6, 2021 By Bartholomew Canton Living Trust F1, F2
transaction DNA Class A Common Stock Gift $0 -200K -100% $0.00* 0 Dec 7, 2021 By Bartholomew Canton Living Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Class B Common Stock Conversion of derivative security -200K -0.28% 70.2M Dec 5, 2021 Class A Common Stock 200K By Bartholomew Canton Living Trust F2, F3, F4
holding DNA Class B Common Stock 3.09M Dec 6, 2021 Class A Common Stock 3.09M Direct F2
holding DNA Class B Common Stock 3.09M Dec 6, 2021 Class A Common Stock 3.09M By Spouse F2
holding DNA Class B Common Stock 70.4M Dec 6, 2021 Class A Common Stock 70.4M By Reshma Padmini Shetty Living Trust F2
holding DNA Class B Common Stock 8.25M Dec 6, 2021 Class A Common Stock 8.25M By Reshma Padmini Shetty GRAT F2
holding DNA Class B Common Stock 8.25M Dec 6, 2021 Class A Common Stock 8.25M By Bartholomew Canton GRAT F2
holding DNA Class B Common Stock 1.29M Dec 6, 2021 Class A Common Stock 1.29M By The Asha S. Canton Irrevocable Trust F2
holding DNA Class B Common Stock 1.29M Dec 6, 2021 Class A Common Stock 1.29M By The Adhira S. Canton Irrevocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions being reported herein relate to a charitable donation of shares of Class A Common Stock. The donated shares remain subject to transfer restrictions in accordance with the Issuer's certificate of incorporation.
F2 Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F3 Pursuant to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. ("Legacy Ginkgo"), as contemplated by an agreement and plan of merger, dated May 11, 2021 and amended on May 14, 2021 (the "Merger Agreement"), (a) each share of Class A common stock of Legacy Ginkgo outstanding immediately prior to the effective time of the business combination was converted into approximately 49.080452 shares of the Issuer's Class A Common Stock; and (b) each share of Class B common stock of Legacy Ginkgo outstanding immediately prior to the effective time of the business combination was converted into approximately 49.080452 shares of the Issuer's Class B Common Stock.
F4 Pursuant to the Merger Agreement, each share of Class A common stock of Legacy Ginkgo, each share of Class B common stock of Legacy Ginkgo, each option of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, each award of restricted common stock of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, and each award of restricted stock units of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, in each case outstanding immediately prior to the effective time of the business combination, received a proportional amount of the approximately 188.7 million earn-out shares.

Remarks:

President, COO & Founder